🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
1.370
-0.060 (-4.20%)
Nov 18, 2026, 4:00 PM EST - Market closed

Kalaris Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
33158---
Market Cap Growth
-67.83%----
Enterprise Value
-4982---
Last Close Price
1.378.44---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
0.692.00---
P/TBV Ratio
0.692.00---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
-0.02-0.39--0.61
Net Debt / Equity Ratio
-1.75-1.48-0.365.20-0.04
Net Debt / EBITDA Ratio
1.772.53---
Net Debt / FCF Ratio
-3.02-0.880.22-0.02
Quick Ratio
9.7312.150.070.800.54
Current Ratio
10.0012.230.110.850.69
Return on Equity (ROE)
-97.22%-308.10%---
Return on Assets (ROA)
-34.40%-45.11%-681.04%-232.72%-
Return on Capital Employed (ROCE)
-58.20%-41.20%279.00%2210.80%781.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-139.57%-27.52%---
FCF Yield
-126.38%-24.44%---
Buyback Yield / Dilution
-41.55%-1042.87%77.99%-36.56%-